HOUSE COMMERCE CMTE. REJECTS TWO AMENDMENTS ON MEDICARE FRAUD/KICKBACK; REFORM BILL POSES "INSURMOUNTABLE" HURDLE TO ENFORCEMENT, HHS IG ASSERTS
This article was originally published in The Gray Sheet
The House Commerce Committee defeated two Democratic amendments during its mark-up of the Medicare reform bill that would have deleted House leadership provisions raising the level of intent that federal prosecutors must prove in civil monetary penalties and anti-kickback actions.
You may also be interested in...
Perrigo, Pfizer want the US FDA to postpone its March 1 deadline for conducting nitrosamine risk assessments. Generics exec cites“serious compliance challenges” in conducting these assessments due to difficulty in finding the right lab equipment necessary to quantify nitrosamine daily intake limits.
Deal snapshot: For $425m up front, the pharma obtains a Phase III recombination fusion protein that shows ability to improve hospitalized patients’ clinical status and reduce risk of death.
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.